0001203311-22-000053.txt : 20220817 0001203311-22-000053.hdr.sgml : 20220817 20220817211426 ACCESSION NUMBER: 0001203311-22-000053 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220815 FILED AS OF DATE: 20220817 DATE AS OF CHANGE: 20220817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LIU JEAN I CENTRAL INDEX KEY: 0001241357 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 221176148 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seagen Inc. CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA DATE OF NAME CHANGE: 20001116 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2022-08-15 0 0001060736 Seagen Inc. SGEN 0001241357 LIU JEAN I 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 Chief Legal Officer Common Stock 2022-08-15 4 A 0 13731 0.0 A 89677 D Common Stock 2022-08-16 4 S 0 922 170.2151 D 88755 D Common Stock 2022-08-16 4 S 0 717 170.2151 D 88038 D These shares represent restricted stock units and will be settled in common stock upon vesting. Shares shall vest at a rate of 25% on each anniversary of August 15, 2022 until all shares are fully vested at the end of four years. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. By: /s/ Jennifer Prosba For: Jean I. Liu 2022-08-17